Bristol-Myers Squibb (BMY) announces positive Phase 3 results from SUCCESSOR-2 study
Importance
Level 1
#BRISTOL-MYERS SQUIBB CO#BMY.US#EQUITIES#EU SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#BMY#US EQUITIES